| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetoscopy | 32 | 2024 | 405 | 4.860 |
Why?
|
| Fetofetal Transfusion | 19 | 2024 | 186 | 4.500 |
Why?
|
| Pregnancy | 107 | 2024 | 8105 | 3.130 |
Why?
|
| Placenta Accreta | 18 | 2024 | 137 | 3.050 |
Why?
|
| Pregnancy, Twin | 21 | 2023 | 171 | 2.780 |
Why?
|
| Extracorporeal Membrane Oxygenation | 7 | 2024 | 638 | 1.950 |
Why?
|
| Delivery, Obstetric | 7 | 2022 | 259 | 1.750 |
Why?
|
| Neural Tube Defects | 11 | 2024 | 369 | 1.720 |
Why?
|
| Pregnancy Complications | 7 | 2022 | 560 | 1.630 |
Why?
|
| Ultrasonography, Prenatal | 24 | 2024 | 914 | 1.520 |
Why?
|
| Obstetrics | 6 | 2023 | 244 | 1.520 |
Why?
|
| Pregnancy Outcome | 17 | 2023 | 681 | 1.480 |
Why?
|
| Gestational Age | 25 | 2024 | 1153 | 1.480 |
Why?
|
| Cesarean Section | 20 | 2023 | 401 | 1.360 |
Why?
|
| Fetal Growth Retardation | 6 | 2023 | 232 | 1.350 |
Why?
|
| Premature Birth | 11 | 2023 | 405 | 1.320 |
Why?
|
| Pre-Eclampsia | 4 | 2023 | 235 | 1.260 |
Why?
|
| Placenta Previa | 8 | 2023 | 66 | 1.200 |
Why?
|
| Prenatal Care | 9 | 2023 | 347 | 1.140 |
Why?
|
| Peripartum Period | 2 | 2024 | 34 | 1.140 |
Why?
|
| Prenatal Diagnosis | 8 | 2024 | 609 | 1.120 |
Why?
|
| Fetal Membranes, Premature Rupture | 4 | 2021 | 59 | 1.110 |
Why?
|
| Placenta | 13 | 2023 | 566 | 1.100 |
Why?
|
| Critical Care | 5 | 2023 | 810 | 1.030 |
Why?
|
| Fetal Diseases | 8 | 2024 | 449 | 1.020 |
Why?
|
| Gastroschisis | 3 | 2021 | 52 | 0.990 |
Why?
|
| Infant, Newborn | 35 | 2024 | 8612 | 0.940 |
Why?
|
| Hysterectomy | 13 | 2023 | 649 | 0.930 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2016 | 92 | 0.930 |
Why?
|
| Laser Therapy | 6 | 2022 | 465 | 0.920 |
Why?
|
| Meningomyelocele | 7 | 2023 | 209 | 0.900 |
Why?
|
| Female | 110 | 2024 | 149288 | 0.900 |
Why?
|
| Labor, Obstetric | 2 | 2022 | 99 | 0.840 |
Why?
|
| Blood Coagulation Disorders | 2 | 2021 | 116 | 0.830 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2023 | 81 | 0.810 |
Why?
|
| Pregnancy, Ectopic | 1 | 2022 | 38 | 0.810 |
Why?
|
| Weight Gain | 2 | 2016 | 474 | 0.790 |
Why?
|
| Magnesium Sulfate | 2 | 2021 | 55 | 0.790 |
Why?
|
| Hysterotomy | 8 | 2024 | 105 | 0.780 |
Why?
|
| Gynecology | 1 | 2024 | 235 | 0.770 |
Why?
|
| Maternal Mortality | 2 | 2020 | 81 | 0.770 |
Why?
|
| Pregnancy, Triplet | 2 | 2022 | 10 | 0.770 |
Why?
|
| Laser Coagulation | 7 | 2023 | 141 | 0.740 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2021 | 40 | 0.740 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2024 | 113 | 0.740 |
Why?
|
| Postoperative Complications | 7 | 2021 | 5693 | 0.730 |
Why?
|
| Retrospective Studies | 59 | 2024 | 39831 | 0.730 |
Why?
|
| Spinal Dysraphism | 5 | 2023 | 264 | 0.720 |
Why?
|
| Cicatrix | 1 | 2022 | 188 | 0.720 |
Why?
|
| Trachea | 2 | 2019 | 290 | 0.710 |
Why?
|
| Blood Coagulation | 1 | 2021 | 168 | 0.690 |
Why?
|
| Laryngoscopy | 2 | 2019 | 199 | 0.650 |
Why?
|
| Lasers | 4 | 2023 | 238 | 0.640 |
Why?
|
| Humans | 112 | 2024 | 272087 | 0.640 |
Why?
|
| Maternal Death | 1 | 2018 | 8 | 0.620 |
Why?
|
| Airway Obstruction | 2 | 2019 | 272 | 0.610 |
Why?
|
| Fetus | 9 | 2023 | 674 | 0.600 |
Why?
|
| Bradycardia | 1 | 2018 | 74 | 0.600 |
Why?
|
| Hypothermia | 1 | 2018 | 67 | 0.590 |
Why?
|
| Hemangioma | 1 | 2019 | 161 | 0.580 |
Why?
|
| Intensive Care Units | 2 | 2022 | 743 | 0.570 |
Why?
|
| Placenta Diseases | 3 | 2018 | 60 | 0.570 |
Why?
|
| Fetal Weight | 4 | 2023 | 53 | 0.560 |
Why?
|
| Obstetric Labor Complications | 2 | 2018 | 98 | 0.560 |
Why?
|
| Embolism, Amniotic Fluid | 1 | 2016 | 32 | 0.550 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2018 | 238 | 0.530 |
Why?
|
| Postpartum Hemorrhage | 4 | 2023 | 89 | 0.530 |
Why?
|
| Umbilical Arteries | 4 | 2021 | 93 | 0.510 |
Why?
|
| Heart Valve Diseases | 1 | 2016 | 197 | 0.490 |
Why?
|
| Delphi Technique | 3 | 2024 | 275 | 0.470 |
Why?
|
| Erythrocyte Transfusion | 4 | 2020 | 211 | 0.460 |
Why?
|
| Adult | 53 | 2024 | 81933 | 0.450 |
Why?
|
| Amnion | 2 | 2020 | 42 | 0.440 |
Why?
|
| Pregnancy Trimester, Second | 7 | 2024 | 169 | 0.430 |
Why?
|
| Light Coagulation | 2 | 2023 | 26 | 0.430 |
Why?
|
| Heart Defects, Congenital | 4 | 2017 | 1782 | 0.420 |
Why?
|
| Labor Presentation | 2 | 2022 | 12 | 0.410 |
Why?
|
| Triplets | 1 | 2012 | 13 | 0.410 |
Why?
|
| Walking | 3 | 2024 | 274 | 0.410 |
Why?
|
| Urethral Obstruction | 3 | 2024 | 61 | 0.410 |
Why?
|
| Blood Loss, Surgical | 5 | 2019 | 294 | 0.400 |
Why?
|
| Cohort Studies | 18 | 2023 | 9500 | 0.390 |
Why?
|
| Amniotic Band Syndrome | 3 | 2020 | 25 | 0.380 |
Why?
|
| Diseases in Twins | 2 | 2021 | 109 | 0.370 |
Why?
|
| Hydrocephalus | 3 | 2024 | 260 | 0.370 |
Why?
|
| Iatrogenic Disease | 2 | 2022 | 197 | 0.360 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 3 | 2021 | 374 | 0.350 |
Why?
|
| Pregnancy Trimester, First | 3 | 2022 | 126 | 0.350 |
Why?
|
| Urologic Diseases | 2 | 2021 | 84 | 0.350 |
Why?
|
| Ultrasonography, Doppler | 4 | 2020 | 276 | 0.340 |
Why?
|
| Consensus | 2 | 2024 | 1116 | 0.330 |
Why?
|
| Uterine Hemorrhage | 2 | 2020 | 64 | 0.330 |
Why?
|
| Fetal Death | 3 | 2021 | 134 | 0.330 |
Why?
|
| Maternal Age | 4 | 2017 | 147 | 0.320 |
Why?
|
| Motor Activity | 3 | 2021 | 718 | 0.310 |
Why?
|
| Twins, Monozygotic | 4 | 2023 | 137 | 0.300 |
Why?
|
| Vasa Previa | 2 | 2019 | 8 | 0.300 |
Why?
|
| Young Adult | 15 | 2023 | 22142 | 0.290 |
Why?
|
| Patient Positioning | 2 | 2020 | 196 | 0.290 |
Why?
|
| Treatment Outcome | 17 | 2024 | 33909 | 0.270 |
Why?
|
| Twins | 3 | 2021 | 78 | 0.270 |
Why?
|
| Patient Care Team | 4 | 2019 | 830 | 0.260 |
Why?
|
| Blood Component Transfusion | 3 | 2021 | 89 | 0.250 |
Why?
|
| Intraoperative Complications | 2 | 2021 | 288 | 0.250 |
Why?
|
| Nuchal Translucency Measurement | 2 | 2014 | 18 | 0.230 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2023 | 432 | 0.230 |
Why?
|
| Pregnant Women | 2 | 2022 | 157 | 0.230 |
Why?
|
| Hypoxia | 2 | 2020 | 477 | 0.220 |
Why?
|
| Polyhydramnios | 3 | 2019 | 51 | 0.220 |
Why?
|
| ROC Curve | 3 | 2022 | 1248 | 0.220 |
Why?
|
| Conservative Treatment | 1 | 2023 | 66 | 0.220 |
Why?
|
| Pulsatile Flow | 2 | 2021 | 143 | 0.220 |
Why?
|
| Angioedemas, Hereditary | 1 | 2022 | 8 | 0.210 |
Why?
|
| Angioedema | 1 | 2022 | 22 | 0.210 |
Why?
|
| Tocolytic Agents | 1 | 2021 | 12 | 0.200 |
Why?
|
| Corpus Callosum | 1 | 2022 | 134 | 0.200 |
Why?
|
| Indomethacin | 1 | 2021 | 115 | 0.200 |
Why?
|
| Fertilization in Vitro | 2 | 2020 | 211 | 0.200 |
Why?
|
| Ureter | 1 | 2023 | 227 | 0.190 |
Why?
|
| Labor Stage, Second | 1 | 2021 | 20 | 0.190 |
Why?
|
| Odds Ratio | 3 | 2021 | 2335 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 5107 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2024 | 7958 | 0.190 |
Why?
|
| Pregnancy Trimesters | 1 | 2021 | 34 | 0.190 |
Why?
|
| Blood Coagulation Tests | 1 | 2021 | 83 | 0.180 |
Why?
|
| Incidence | 5 | 2022 | 5864 | 0.180 |
Why?
|
| Maternal Health Services | 1 | 2020 | 38 | 0.180 |
Why?
|
| Wound Closure Techniques | 1 | 2020 | 33 | 0.180 |
Why?
|
| Risk Factors | 14 | 2023 | 18051 | 0.180 |
Why?
|
| Ascites | 1 | 2021 | 216 | 0.180 |
Why?
|
| Spina Bifida Cystica | 1 | 2020 | 36 | 0.180 |
Why?
|
| Thrombelastography | 1 | 2021 | 65 | 0.180 |
Why?
|
| Prone Position | 1 | 2020 | 60 | 0.180 |
Why?
|
| White Matter | 1 | 2022 | 189 | 0.180 |
Why?
|
| Reproductive Techniques, Assisted | 2 | 2017 | 99 | 0.170 |
Why?
|
| Ultrasonography | 3 | 2022 | 1943 | 0.170 |
Why?
|
| Fetal Development | 2 | 2019 | 118 | 0.170 |
Why?
|
| Birth Weight | 5 | 2022 | 352 | 0.170 |
Why?
|
| Respiratory Insufficiency | 1 | 2023 | 348 | 0.170 |
Why?
|
| Prospective Studies | 4 | 2022 | 13410 | 0.170 |
Why?
|
| Thulium | 1 | 2019 | 6 | 0.170 |
Why?
|
| Remission, Spontaneous | 1 | 2019 | 126 | 0.170 |
Why?
|
| Placenta Growth Factor | 1 | 2019 | 25 | 0.170 |
Why?
|
| Abdominal Wall | 1 | 2021 | 192 | 0.160 |
Why?
|
| United States | 10 | 2022 | 16066 | 0.160 |
Why?
|
| Uterine Artery | 1 | 2019 | 31 | 0.160 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2018 | 14 | 0.160 |
Why?
|
| Obstetric Labor, Premature | 1 | 2019 | 85 | 0.160 |
Why?
|
| Hypocalcemia | 1 | 2019 | 59 | 0.160 |
Why?
|
| Carbon Dioxide | 4 | 2023 | 331 | 0.160 |
Why?
|
| Respiration, Artificial | 1 | 2022 | 583 | 0.160 |
Why?
|
| Treatment Failure | 1 | 2022 | 1433 | 0.160 |
Why?
|
| Polycythemia | 2 | 2016 | 65 | 0.160 |
Why?
|
| Pandemics | 3 | 2022 | 1607 | 0.160 |
Why?
|
| Neurosurgical Procedures | 2 | 2020 | 646 | 0.160 |
Why?
|
| Meningocele | 1 | 2018 | 22 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2019 | 122 | 0.160 |
Why?
|
| Placental Circulation | 2 | 2020 | 24 | 0.150 |
Why?
|
| Vasoconstrictor Agents | 1 | 2019 | 167 | 0.150 |
Why?
|
| Endometrial Ablation Techniques | 1 | 2017 | 3 | 0.150 |
Why?
|
| Angiotensin II | 1 | 2019 | 204 | 0.150 |
Why?
|
| Cold Temperature | 1 | 2018 | 127 | 0.150 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2019 | 129 | 0.150 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 152 | 0.150 |
Why?
|
| Heart Rate, Fetal | 1 | 2018 | 64 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 2430 | 0.150 |
Why?
|
| Hospital Rapid Response Team | 1 | 2018 | 37 | 0.150 |
Why?
|
| Catheters, Indwelling | 2 | 2021 | 383 | 0.140 |
Why?
|
| Hydrops Fetalis | 1 | 2017 | 74 | 0.140 |
Why?
|
| Intestines | 1 | 2021 | 740 | 0.140 |
Why?
|
| Patient Transfer | 1 | 2018 | 138 | 0.140 |
Why?
|
| Disease Management | 3 | 2018 | 1113 | 0.140 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2017 | 58 | 0.140 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2016 | 35 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 460 | 0.140 |
Why?
|
| Maternal Exposure | 1 | 2018 | 153 | 0.140 |
Why?
|
| Risk Adjustment | 1 | 2016 | 77 | 0.140 |
Why?
|
| Severity of Illness Index | 4 | 2020 | 4400 | 0.140 |
Why?
|
| Cystoscopy | 1 | 2016 | 92 | 0.130 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 2014 | 89 | 0.130 |
Why?
|
| Patient Care Management | 1 | 2016 | 94 | 0.130 |
Why?
|
| Infertility, Female | 1 | 2017 | 210 | 0.130 |
Why?
|
| Arm Injuries | 1 | 2015 | 18 | 0.130 |
Why?
|
| Gravidity | 1 | 2015 | 15 | 0.130 |
Why?
|
| Inositol Phosphates | 1 | 2015 | 27 | 0.130 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2019 | 253 | 0.130 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 418 | 0.130 |
Why?
|
| Inositol | 1 | 2015 | 27 | 0.130 |
Why?
|
| Simulation Training | 1 | 2018 | 162 | 0.130 |
Why?
|
| Hospital Mortality | 1 | 2022 | 1317 | 0.130 |
Why?
|
| Case-Control Studies | 6 | 2023 | 6236 | 0.130 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 4513 | 0.130 |
Why?
|
| Neuroimaging | 1 | 2019 | 404 | 0.130 |
Why?
|
| Lymphatic Abnormalities | 1 | 2015 | 30 | 0.130 |
Why?
|
| Survival Analysis | 3 | 2022 | 9326 | 0.130 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 276 | 0.120 |
Why?
|
| Ovary | 1 | 2018 | 701 | 0.120 |
Why?
|
| Mothers | 1 | 2018 | 418 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 1 | 2019 | 472 | 0.120 |
Why?
|
| Laparoscopy | 3 | 2013 | 1298 | 0.120 |
Why?
|
| Polysaccharides | 1 | 2015 | 195 | 0.120 |
Why?
|
| Term Birth | 1 | 2013 | 34 | 0.110 |
Why?
|
| Pleural Effusion | 1 | 2015 | 219 | 0.110 |
Why?
|
| Diabetes, Gestational | 1 | 2015 | 115 | 0.110 |
Why?
|
| Fetal Therapies | 1 | 2013 | 73 | 0.110 |
Why?
|
| Infant | 8 | 2021 | 13970 | 0.110 |
Why?
|
| Vocal Cords | 1 | 2013 | 105 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 633 | 0.100 |
Why?
|
| Patient Safety | 1 | 2018 | 655 | 0.100 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 709 | 0.100 |
Why?
|
| Receptors, Opioid, mu | 1 | 2013 | 96 | 0.100 |
Why?
|
| Hydronephrosis | 1 | 2012 | 51 | 0.100 |
Why?
|
| Ehrlichiosis | 1 | 2011 | 19 | 0.100 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2011 | 34 | 0.100 |
Why?
|
| Logistic Models | 4 | 2021 | 3469 | 0.100 |
Why?
|
| Angiogenic Proteins | 1 | 2011 | 39 | 0.100 |
Why?
|
| Blood Coagulation Factors | 1 | 2011 | 55 | 0.100 |
Why?
|
| Peritoneal Lavage | 1 | 2011 | 21 | 0.100 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2013 | 181 | 0.100 |
Why?
|
| Ovarian Cysts | 1 | 2011 | 41 | 0.100 |
Why?
|
| Infant, Premature, Diseases | 1 | 2013 | 248 | 0.100 |
Why?
|
| Complement System Proteins | 1 | 2011 | 136 | 0.090 |
Why?
|
| Limb Deformities, Congenital | 1 | 2012 | 116 | 0.090 |
Why?
|
| Dermoid Cyst | 1 | 2011 | 39 | 0.090 |
Why?
|
| Morphine | 1 | 2013 | 332 | 0.090 |
Why?
|
| Peritonitis | 1 | 2011 | 101 | 0.090 |
Why?
|
| Down Syndrome | 1 | 2013 | 227 | 0.090 |
Why?
|
| Anemia | 1 | 2016 | 730 | 0.090 |
Why?
|
| Laparotomy | 2 | 2023 | 231 | 0.090 |
Why?
|
| Antihypertensive Agents | 1 | 2013 | 439 | 0.090 |
Why?
|
| Amniotic Fluid | 2 | 2021 | 152 | 0.080 |
Why?
|
| Postnatal Care | 2 | 2019 | 51 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2013 | 666 | 0.080 |
Why?
|
| Sensitivity and Specificity | 5 | 2017 | 5196 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2016 | 2259 | 0.080 |
Why?
|
| Perinatal Mortality | 2 | 2019 | 42 | 0.080 |
Why?
|
| Postpartum Period | 2 | 2023 | 261 | 0.080 |
Why?
|
| Endometrium | 1 | 2011 | 469 | 0.080 |
Why?
|
| Blood Transfusion | 2 | 2023 | 583 | 0.080 |
Why?
|
| Endometriosis | 1 | 2010 | 235 | 0.070 |
Why?
|
| Kidney | 2 | 2013 | 2266 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 5001 | 0.070 |
Why?
|
| Endoscopy | 2 | 2019 | 501 | 0.070 |
Why?
|
| Prognosis | 6 | 2024 | 22555 | 0.070 |
Why?
|
| Child, Preschool | 4 | 2024 | 17056 | 0.060 |
Why?
|
| Brain | 1 | 2019 | 4257 | 0.060 |
Why?
|
| Thrombosis | 1 | 2011 | 755 | 0.060 |
Why?
|
| Mesothelioma | 1 | 2010 | 560 | 0.060 |
Why?
|
| Mass Screening | 1 | 2013 | 1548 | 0.060 |
Why?
|
| Biomarkers | 2 | 2015 | 5115 | 0.060 |
Why?
|
| Cerebral Ventricles | 1 | 2024 | 107 | 0.060 |
Why?
|
| Perinatal Care | 1 | 2024 | 68 | 0.060 |
Why?
|
| Peritoneal Neoplasms | 1 | 2010 | 857 | 0.060 |
Why?
|
| Connecticut | 2 | 2013 | 37 | 0.050 |
Why?
|
| Complement C1 Inhibitor Protein | 1 | 2022 | 8 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2023 | 398 | 0.050 |
Why?
|
| Inflammation | 1 | 2011 | 2535 | 0.050 |
Why?
|
| Organ Sparing Treatments | 1 | 2023 | 280 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 6210 | 0.050 |
Why?
|
| Urinary Bladder | 1 | 2024 | 601 | 0.050 |
Why?
|
| Waist Circumference | 1 | 2021 | 100 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 566 | 0.050 |
Why?
|
| Mental Health Services | 1 | 2024 | 257 | 0.050 |
Why?
|
| Cervix Uteri | 1 | 2023 | 252 | 0.050 |
Why?
|
| Male | 9 | 2024 | 129088 | 0.050 |
Why?
|
| Perineum | 1 | 2021 | 116 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 4900 | 0.050 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2020 | 59 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2022 | 295 | 0.040 |
Why?
|
| Texas | 2 | 2021 | 6440 | 0.040 |
Why?
|
| Live Birth | 1 | 2020 | 59 | 0.040 |
Why?
|
| Infant, Premature | 2 | 2017 | 828 | 0.040 |
Why?
|
| Insufflation | 1 | 2020 | 27 | 0.040 |
Why?
|
| Positive-Pressure Respiration | 1 | 2020 | 124 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2022 | 215 | 0.040 |
Why?
|
| Lung Volume Measurements | 1 | 2019 | 97 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 349 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 7476 | 0.040 |
Why?
|
| Oligohydramnios | 1 | 2019 | 42 | 0.040 |
Why?
|
| Choroid Plexus | 1 | 2019 | 37 | 0.040 |
Why?
|
| Ventriculostomy | 1 | 2019 | 42 | 0.040 |
Why?
|
| Umbilical Veins | 1 | 2019 | 119 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2024 | 605 | 0.040 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2019 | 101 | 0.040 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2019 | 52 | 0.040 |
Why?
|
| Platelet Transfusion | 1 | 2019 | 168 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2019 | 259 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2020 | 671 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2018 | 165 | 0.040 |
Why?
|
| Plasma | 1 | 2019 | 147 | 0.040 |
Why?
|
| Placenta, Retained | 1 | 2017 | 12 | 0.040 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2018 | 89 | 0.040 |
Why?
|
| Meningitis | 1 | 2018 | 127 | 0.040 |
Why?
|
| Norwood Procedures | 1 | 2019 | 101 | 0.040 |
Why?
|
| Isotonic Solutions | 1 | 2017 | 42 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2021 | 968 | 0.040 |
Why?
|
| Pulmonary Veins | 1 | 2019 | 180 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2017 | 148 | 0.040 |
Why?
|
| United Kingdom | 1 | 2017 | 289 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2017 | 117 | 0.030 |
Why?
|
| Breech Presentation | 1 | 2016 | 21 | 0.030 |
Why?
|
| Menorrhagia | 1 | 2017 | 76 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2017 | 170 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2020 | 1589 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 690 | 0.030 |
Why?
|
| Heart Atria | 1 | 2019 | 357 | 0.030 |
Why?
|
| Portal Vein | 1 | 2019 | 364 | 0.030 |
Why?
|
| Emergencies | 1 | 2017 | 227 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2017 | 425 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 203 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 2058 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2015 | 95 | 0.030 |
Why?
|
| Critical Illness | 1 | 2021 | 743 | 0.030 |
Why?
|
| Middle Aged | 6 | 2021 | 90460 | 0.030 |
Why?
|
| Arm | 1 | 2015 | 138 | 0.030 |
Why?
|
| Recurrence | 1 | 2023 | 4887 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 522 | 0.030 |
Why?
|
| Biometry | 1 | 2017 | 249 | 0.030 |
Why?
|
| Prevalence | 2 | 2013 | 3427 | 0.030 |
Why?
|
| Crown-Rump Length | 1 | 2014 | 5 | 0.030 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2013 | 13 | 0.030 |
Why?
|
| Patient Selection | 1 | 2021 | 2045 | 0.030 |
Why?
|
| Arteriovenous Anastomosis | 1 | 2013 | 5 | 0.030 |
Why?
|
| Random Allocation | 1 | 2015 | 746 | 0.030 |
Why?
|
| Abortion, Eugenic | 1 | 2013 | 9 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2019 | 6885 | 0.030 |
Why?
|
| Registries | 1 | 2022 | 2253 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 1241 | 0.030 |
Why?
|
| Umbilical Cord | 1 | 2013 | 61 | 0.030 |
Why?
|
| Retinopathy of Prematurity | 1 | 2013 | 56 | 0.030 |
Why?
|
| Nitrates | 1 | 2013 | 46 | 0.030 |
Why?
|
| Drainage | 1 | 2015 | 448 | 0.030 |
Why?
|
| Karyotype | 1 | 2013 | 237 | 0.030 |
Why?
|
| Nitrites | 1 | 2013 | 69 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2017 | 649 | 0.030 |
Why?
|
| Abortion, Induced | 1 | 2013 | 93 | 0.030 |
Why?
|
| Placentation | 1 | 2013 | 63 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2019 | 1603 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 4352 | 0.030 |
Why?
|
| Stents | 1 | 2019 | 1015 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2013 | 324 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 1 | 2013 | 189 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2017 | 632 | 0.030 |
Why?
|
| Tick-Borne Diseases | 1 | 2011 | 10 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 2013 | 329 | 0.020 |
Why?
|
| Narcotic Antagonists | 1 | 2013 | 154 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2016 | 1055 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2013 | 322 | 0.020 |
Why?
|
| Reference Values | 1 | 2013 | 1155 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 771 | 0.020 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2013 | 184 | 0.020 |
Why?
|
| Dissection | 1 | 2011 | 134 | 0.020 |
Why?
|
| Omentum | 1 | 2011 | 107 | 0.020 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2013 | 237 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 727 | 0.020 |
Why?
|
| Pelvic Pain | 1 | 2010 | 47 | 0.020 |
Why?
|
| Syndrome | 1 | 2013 | 1407 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2011 | 372 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 318 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2011 | 239 | 0.020 |
Why?
|
| Liver | 1 | 2019 | 3123 | 0.020 |
Why?
|
| Lung | 1 | 2020 | 3295 | 0.020 |
Why?
|
| Algorithms | 1 | 2020 | 3925 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 2256 | 0.020 |
Why?
|
| Sepsis | 1 | 2013 | 689 | 0.020 |
Why?
|
| Adolescent | 2 | 2019 | 32730 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 3856 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 2457 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 1966 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6270 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 6640 | 0.010 |
Why?
|
| Survival Rate | 1 | 2015 | 12534 | 0.010 |
Why?
|
| Child | 1 | 2022 | 30559 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 5756 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 3176 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 15279 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 62822 | 0.000 |
Why?
|